Treace Medical Concepts, Inc.

NasdaqGS:TMCI Stock Report

Market Cap: US$672.6m

Treace Medical Concepts Management

Management criteria checks 2/4

Treace Medical Concepts' CEO is John Treace, appointed in Jul 2014, has a tenure of 9.75 years. total yearly compensation is $8.42M, comprised of 8.1% salary and 91.9% bonuses, including company stock and options. directly owns 17.69% of the company’s shares, worth $119.01M. The average tenure of the management team and the board of directors is 2.5 years and 6.3 years respectively.

Key information

John Treace

Chief executive officer

US$8.4m

Total compensation

CEO salary percentage8.1%
CEO tenure9.8yrs
CEO ownership17.7%
Management average tenure2.5yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Apr 05
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Feb 09
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Jan 04
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Nov 11
Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Aug 13
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

CEO Compensation Analysis

How has John Treace's remuneration changed compared to Treace Medical Concepts's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$8mUS$684k

-US$50m

Sep 30 2023n/an/a

-US$48m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$4mUS$568k

-US$43m

Sep 30 2022n/an/a

-US$45m

Jun 30 2022n/an/a

-US$39m

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$688kUS$410k

-US$21m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$392kUS$316k

-US$4m

Compensation vs Market: John's total compensation ($USD8.42M) is above average for companies of similar size in the US market ($USD3.43M).

Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.


CEO

John Treace (51 yo)

9.8yrs

Tenure

US$8,422,635

Compensation

Mr. John T. Treace Founded Treace Medical Concepts, Inc. in 2014 and has been its Chief Executive Officer and Director since July 1, 2014. Before that, Mr. Treace served as Senior Vice President of U.S. Sa...


Leadership Team

NamePositionTenureCompensationOwnership
John Treace
CEO, Founder & Director9.8yrsUS$8.42m17.69%
$ 119.0m
Mark Hair
Chief Financial Officer3.6yrsUS$4.69m0.033%
$ 223.2k
Aaron Berutti
Senior Vice President of Sales2.7yrsUS$3.26m0.0066%
$ 44.3k
Terry Lubben
Senior Vice President of Operations2.6yrsno datano data
Taylor Erickson
Chief Information & Security Officer2.1yrsno datano data
Julie Dewey
Chief Communications & Investor Relations Officerless than a yearno datano data
Scot Elder
Chief Legal & Compliance Officer and Corporate Secretary2.5yrsno data0.0069%
$ 46.5k
Nathan Minnich
Senior Vice President of Marketingless than a yearno datano data
Daniel Owens
Chief Human Resources Officer3.2yrsno data0.0085%
$ 57.2k
Sean Scanlan
Chief Innovation Officer1.3yrsno data0.0018%
$ 12.4k
Shana Zink
Senior Vice President of Clinical Affairsno datano datano data
Rachel Osbeck
Senior Vice President of Quality Assurance & Regulatory Affairsno datano datano data

2.5yrs

Average Tenure

51yo

Average Age

Experienced Management: TMCI's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
John Treace
CEO, Founder & Director9.8yrsUS$8.42m17.69%
$ 119.0m
Lawrence Hamilton
Independent Director3.4yrsUS$214.79k0.0037%
$ 25.0k
James Treace
Chairman of the Board9.8yrsUS$94.74k2.21%
$ 14.9m
Richard Mott
Independent Director9.1yrsUS$197.26k1.46%
$ 9.8m
John Bakewell
Independent Director3.4yrsUS$214.79k0.56%
$ 3.7m
Deepti Jain
Independent Director2.5yrsUS$209.79k0.0043%
$ 29.2k
Paul Dayton
Member of the Surgeon Advisory Boardno datano datano data
William DeCarbo
Member of the Surgeon Advisory Boardno datano datano data
Daniel Hatch
Member of the Surgeon Advisory Boardno datano datano data
J.P. McAleer
Member of the Surgeon Advisory Boardno datano datano data
W. Smith
Member of the Surgeon Advisory Boardno datano datano data
Robert Santrock
Member of the Surgeon Advisory Boardno datano datano data

6.3yrs

Average Tenure

62.5yo

Average Age

Experienced Board: TMCI's board of directors are considered experienced (6.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.